841 results match your criteria: "Medical Clinic III.[Affiliation]"

Boosting human immunology: harnessing the potential of immune organoids.

EMBO Mol Med

January 2025

Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Studying the human immune system in vivo is challenging and often not possible. Therefore, most human immunology studies have been predominantly confined to peripheral blood analyses, which by themselves have inherent limitations, as many immune reactions take place within tissues. For example, potent antibody responses that contribute to fighting infections and provide protection following vaccination require cellular interactions between B cells and T cells in specialized micro-anatomical structures called germinal centers, which are found in secondary lymphoid organs such as spleen, lymph nodes, and tonsils.

View Article and Find Full Text PDF

Regarding: Alpha-1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study.

J Intern Med

February 2025

Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.

View Article and Find Full Text PDF

Importance: Progressive disease (PD) in patients treated with immune checkpoint inhibitors (ICIs) varies widely in outcomes according to the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1. Efforts to modify RECIST for ICI treatment have not resolved the heterogeneity in PD patterns, posing a clinical challenge.

View Article and Find Full Text PDF

Introduction: Malaria remains a significant burden, and a fully protective vaccine against is critical for reducing morbidity and mortality. Antibody responses against the blood-stage antigen Merozoite Surface Protein 2 (MSP2) are associated with protection from malaria, but its extensive polymorphism is a barrier to its development as a vaccine candidate. New tools, such as long-read sequencing and accurate protein structure modelling allow us to study the genetic diversity and immune responses towards antigens from clinical isolates with unprecedented detail.

View Article and Find Full Text PDF

Background: Arterial hypertension is a significant risk factor for cardiovascular (CV) morbidity and mortality. Although central blood pressure (BP) evaluation is considered the gold standard, the reliability of non-invasive measurements remains unclear. Therefore, we compared the predictive value of invasively measured central BP with non-invasively measured brachial BP and analyzed pulse pressure (PP) amplification (delta-PP; difference between central and peripheral PP) as an independent predictor of mortality.

View Article and Find Full Text PDF

Non-small cell lung cancer (NSCLC) represents over 80% of lung cancer cases and has a high mortality worldwide, however, targeting common epidermal growth-factor receptor (EGFR) alterations (i.e., del19, L858R) has provided a paradigm shift in the treatment of NSCLC.

View Article and Find Full Text PDF

Even today, a non-invasive biomarker to identify donors with enhanced risk for renal impairment is missing. Dickkopf 3 (DKK3) can cause tubulointerstitial fibrosis and is associated with rapid eGFR loss. The aim of our work was to analyze whether DKK3 can be used as a non-invasive alert marker for an increased risk of loss of kidney function in living kidney donors (LKDs).

View Article and Find Full Text PDF

C-reactive protein (CRP) has long been recognized as a marker of inflammation, but its evolving role in immunomodulation and cancer has increasingly been recognized. In recent years, multiple studies have explored CRP as a biomarker for prognosis and therapy response, particularly in the context of cancer immunotherapy. In this issue of Cancer Research, Feng and colleagues investigate the role of CRP in the development of lung metastasis.

View Article and Find Full Text PDF

Preclinical models of HNSCC and their role in drug discovery - an emphasis on the cancer microenvironment and microbiota.

Expert Opin Drug Discov

January 2025

Department of Internal Medicine, Medical Clinic III - Hematology, Oncology, Palliative Care, University of Rostock, Rostock, Germany.

Introduction: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide. Treatment options and patient outcomes have not improved significantly over the past decades, increasing the need for better preclinical models. Holistic approaches that include an intact and functional immune compartment along with the patient's individual tumor microbiome will help improve the predictive value of novel drug efficacy.

View Article and Find Full Text PDF

Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry.

JACC Cardiovasc Interv

December 2024

Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany. Electronic address:

Article Synopsis
  • Atrial secondary tricuspid regurgitation (A-STR) is a subtype of secondary tricuspid regurgitation (STR) that is often treated with transcatheter tricuspid valve edge-to-edge repair (T-TEER), showing distinct patient characteristics and treatment outcomes.
  • A study involving 641 patients revealed that 31% had A-STR, which was linked to better heart function, a higher presence of atrial fibrillation, and more effective TR reduction post-procedure compared to nonatrial STR patients.
  • A-STR patients experienced improved survival rates and lower symptomatic burdens after treatment; only 38% remained symptomatic (NYHA class ≥III) after 2 years, compared to 46
View Article and Find Full Text PDF

The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression.

Eur J Cancer

January 2025

Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany.

Background: Treatment beyond progression (TBP) is common in patients treated with immune-checkpoint inhibitors (ICI), however, there is no biomarker to select patients that are more likely to derive benefit from TBP. Here, we investigated the potential of the modified Glasgow Prognostic Score (mGPS) as a predictive biomarker to select patients for TBP.

Methods: We performed a post-hoc analysis of the immunotherapy arms in the randomized phase 3 trials IMmotion151 (renal cell carcinoma), OAK (non-small cell lung cancer) and IMvigor211 (urothelial cancer).

View Article and Find Full Text PDF

CMTM6 status predicts survival in head and neck squamous cell carcinoma and correlates with PD-L1 expression.

Discov Oncol

December 2024

Department of Internal Medicine, Medical Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany.

We retrospectively analyzed 129 treatment-naïve head and neck squamous cell carcinomas (HNSCCs) for the expression of programmed death ligand 1 (PD-L1), CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6), tumor-infiltrating leukocytes (TILs), and tumor-associated macrophages (TAMs). We evaluated the relationships among these markers, human papilloma virus (HPV) status, and overall survival (OS). PD-L1 and CMTM6 (combined positive score (CPS) ≥ 1 and ≥ 5) were detected in ~ 70% of HNSCCs.

View Article and Find Full Text PDF

Background: Smoking is a modifiable risk factor for SARS-CoV-2 infection. Evidence of smoking behavior during the pandemic is ambiguous. Most investigations report an increase in smoking.

View Article and Find Full Text PDF

Aims: Conventional parameters of right ventricular (RV) function are load-dependent and therefore do not accurately reflect contractility in patients with relevant tricuspid regurgitation (TR). RV adaptability to load has been characterized using the Dandel's index in patients with heart failure, but its prognostic value in patients undergoing tricuspid transcatheter edge-to-edge repair (T-TEER) has not been investigated so far.

Methods And Results: From the EuroTR registry (2019 to 2022), patients with complete datasets and a minimum of 2-years of follow-up were included.

View Article and Find Full Text PDF

Practical management of severe acute pancreatitis.

Eur J Intern Med

November 2024

Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany. Electronic address:

Article Synopsis
  • Acute pancreatitis (AP) is a leading cause of hospital admissions, increasing healthcare costs and requiring intensive medical management, particularly for severe cases (SAP), which can be life-threatening.
  • Managing SAP involves a multidisciplinary team, including various specialists, to ensure comprehensive care and improve patient outcomes through continuous collaboration.
  • The review discusses the latest diagnostic and treatment strategies for SAP, covering risk assessment, fluid management, nutrition, and interventions for complications, while emphasizing the importance of integrating new evidence into clinical practice.
View Article and Find Full Text PDF

Endoscopic retrograde cholangiopancreatography training conditions, results from a pan-European survey: Between vision and reality.

United European Gastroenterol J

November 2024

Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group of the DGVS - German Society for Digestive and Metabolic Diseases, Berlin, Germany.

Background: Endoscopic retrograde cholangiopancreatography (ERCP) still has a relatively high complication rate, underscoring the importance of high-quality training. Despite existing guidelines, real-world data on training conditions remain limited. This pan-European survey aims to systematically explore the perceptions surrounding ERCP training.

View Article and Find Full Text PDF
Article Synopsis
  • - Cefiderocol is a new antibiotic effective against multidrug-resistant pathogens, showing potential against carbapenem-resistant Pseudomonas aeruginosa (Cr-Pa) infections based on a study of 108 isolates.
  • - Out of these isolates, nine displayed resistance with specific mutations linked to iron uptake systems and other resistance-related genes, while no correlation was found between carbapenemases and cefiderocol resistance.
  • - The study indicates that while cefiderocol remains a viable treatment option, ongoing research is needed to understand the evolving resistance mechanisms and enhance strategies for managing antimicrobial resistance.
View Article and Find Full Text PDF

Current views on paediatric phaeochromocytoma and paraganglioma with a focus on newest guidelines.

Best Pract Res Clin Endocrinol Metab

November 2024

Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Department of Endocrinology, Cambridge Cancer Centre and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address:

Article Synopsis
  • Phaeochromocytoma and paraganglioma (PPGL) are rare tumors that develop from specialized cells in the adrenal gland or nearby nerve tissues, affecting both adults and, less commonly, children.
  • The annual incidence in children is approximately 0.5 cases per million, and there's been significant progress in understanding how to diagnose and treat these tumors, primarily based on adult studies.
  • This article reviews the unique challenges and management strategies for diagnosing and treating pediatric PPGL, including recent international guidelines.
View Article and Find Full Text PDF

Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases.

Cell Biol Toxicol

November 2024

Medical Clinic III for Pneumology, Allergology and Sleep Medicine, Bergmannsheil University Hospital, Ruhr-University Bochum, Bürkle-de-La-Camp-Platz 1, 44789, Bochum, Germany.

Background: Hypersensitivity to odorants like perfumes can induce or promote asthma with non-type 2 inflammation for which therapeutic options are limited. Cell death of primary bronchial epithelial cells (PBECs) and the release of the pro-inflammatory cytokines interleukin-6 (IL-6) and IL-8 are key in the pathogenesis. Extra-nasal olfactory receptors (ORs) can influence cellular processes involved in asthma.

View Article and Find Full Text PDF

The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells.

Cancers (Basel)

November 2024

Medical Clinic III for Hematology, Oncology, Rheumatology, Immunoncology and Stem-Cell Transplantation, University of Bonn, 53127 Bonn, Germany.

Background: FMS-like tyrosine kinase 3 (FLT3) mutations or internal tandem duplication occur in 30% of acute myeloid leukemia (AML) cases. In these cases, FLT3 inhibitors (FLT3i) are approved for induction treatment and relapse. Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the recommended post-induction therapy for suitable patients.

View Article and Find Full Text PDF